Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jana Wiemann

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Bioorganic & Medicinal Chemistry Letters|January 12, 2016
Targeting cancer cells with oleanolic and ursolic acid derived hydroxamatesJana Wiemann, Lucie Heller, René Csuk
European Journal of Medicinal Chemistry|March 13, 2018
An access to a library of novel triterpene derivatives with a promising pharmacological potential by Ugi and Passerini multicomponent reactionsJana Wiemann, Lucie Heller, René Csuk
Bioorganic Chemistry|August 12, 2017
Novel dehydroabietylamine derivatives as potent inhibitors of acetylcholinesteraseJana Wiemann, Anne Loesche, René Csuk
Bioorganic & Medicinal Chemistry Letters|May 14, 2013
A bioassay-driven discovery of an unexpected selenophene and its cytotoxicityRené Csuk, Bianka Siewert, Jana Wiemann
Anti-Cancer Agents in Medicinal Chemistry|March 19, 2020
Cytotoxic Dehydroabietylamine Derived CompoundsJana Wiemann, Ahmed Al-Harrasi, René Csuk
European Journal of Medicinal Chemistry|July 30, 2018
Syntheses of C-ring modified dehydroabietylamides and their cytotoxic activityJana Wiemann, Lucie Fischer, Matthias Rohmer, et al.
European Journal of Medicinal Chemistry|December 24, 2013
The chemical and biological potential of C ring modified triterpenoidsBianka Siewert, Jana Wiemann, Alexander Köwitsch, et al.
Bioorganic Chemistry|July 8, 2019
Novel 12-hydroxydehydroabietylamine derivatives act as potent and selective butyrylcholinesterase inhibitorsAnne Loesche, Jana Wiemann, Matthias Rohmer, et al.
European Journal of Medicinal Chemistry|October 3, 2018
Transformation of asiatic acid into a mitocanic, bimodal-acting rhodamine B conjugate of nanomolar cytotoxicityMichael Kahnt, Jana Wiemann, Lucie Fischer, et al.
Bioorganic & Medicinal Chemistry Letters|May 5, 2016
Amino(oxo)acetate moiety: A new functional group to improve the cytotoxicity of betulin derived carbamatesLucie Heller, Vincent Perl, Jana Wiemann, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Bioorganic & Medicinal Chemistry Letters|January 12, 2016
Targeting cancer cells with oleanolic and ursolic acid derived hydroxamatesJana Wiemann, Lucie Heller, René Csuk
European Journal of Medicinal Chemistry|March 13, 2018
An access to a library of novel triterpene derivatives with a promising pharmacological potential by Ugi and Passerini multicomponent reactionsJana Wiemann, Lucie Heller, René Csuk
Bioorganic Chemistry|August 12, 2017
Novel dehydroabietylamine derivatives as potent inhibitors of acetylcholinesteraseJana Wiemann, Anne Loesche, René Csuk
Bioorganic & Medicinal Chemistry Letters|May 14, 2013
A bioassay-driven discovery of an unexpected selenophene and its cytotoxicityRené Csuk, Bianka Siewert, Jana Wiemann
Anti-Cancer Agents in Medicinal Chemistry|March 19, 2020
Cytotoxic Dehydroabietylamine Derived CompoundsJana Wiemann, Ahmed Al-Harrasi, René Csuk
European Journal of Medicinal Chemistry|July 30, 2018
Syntheses of C-ring modified dehydroabietylamides and their cytotoxic activityJana Wiemann, Lucie Fischer, Matthias Rohmer, et al.
European Journal of Medicinal Chemistry|December 24, 2013
The chemical and biological potential of C ring modified triterpenoidsBianka Siewert, Jana Wiemann, Alexander Köwitsch, et al.
Bioorganic Chemistry|July 8, 2019
Novel 12-hydroxydehydroabietylamine derivatives act as potent and selective butyrylcholinesterase inhibitorsAnne Loesche, Jana Wiemann, Matthias Rohmer, et al.
European Journal of Medicinal Chemistry|October 3, 2018
Transformation of asiatic acid into a mitocanic, bimodal-acting rhodamine B conjugate of nanomolar cytotoxicityMichael Kahnt, Jana Wiemann, Lucie Fischer, et al.
Bioorganic & Medicinal Chemistry Letters|May 5, 2016
Amino(oxo)acetate moiety: A new functional group to improve the cytotoxicity of betulin derived carbamatesLucie Heller, Vincent Perl, Jana Wiemann, et al.
Pageof 2